108 related articles for article (PubMed ID: 38833840)
1. Retraction notice to "LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN" [EBioMedicine 44 (2019) 298-310].
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2024 Jun; 104():105192. PubMed ID: 38833840
[No Abstract] [Full Text] [Related]
2. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN.
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2019 Jun; 44():298-310. PubMed ID: 31201145
[TBL] [Abstract][Full Text] [Related]
3. Serine 727 phosphorylation is necessary to induce the STAT3-mediated transcription of LINC00184 in oesophageal squamous cell carcinoma.
Jin C; Qi H; Xu Y; Li S
Mol Cell Biochem; 2022 Jun; 477(6):1775-1787. PubMed ID: 35312906
[TBL] [Abstract][Full Text] [Related]
4. Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105106. PubMed ID: 38579361
[No Abstract] [Full Text] [Related]
5. Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].
Wang WW; Zhao ZH; Wang L; Li P; Chen KS; Zhang JY; Li WC; Jiang GZ; Li XN
EBioMedicine; 2024 May; 103():105105. PubMed ID: 38579362
[No Abstract] [Full Text] [Related]
6. LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305.
Han Y; You J; Han Y; Liu Y; Huang M; Lu X; Chen J; Zheng Y
Onco Targets Ther; 2021; 14():2711-2726. PubMed ID: 33907415
[TBL] [Abstract][Full Text] [Related]
7. Periplcymarin targets glycolysis and mitochondrial oxidative phosphorylation of esophageal squamous cell carcinoma: Implication in anti-cancer therapy.
Han L; Xiang X; Fu Y; Wei S; Zhang C; Li L; Liu Y; Lv H; Shan B; Zhao L
Phytomedicine; 2024 Jun; 128():155539. PubMed ID: 38522311
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00184 facilitates the proliferation, metastasis, and adenine metabolism of cholangiocarcinoma via modulating hsa-miR-23b-3p/ANXA2 axis.
Sun HB; Zhang GC; Liu J; Nie CS
Environ Toxicol; 2021 Aug; 36(8):1576-1590. PubMed ID: 33913242
[TBL] [Abstract][Full Text] [Related]
9. Retraction notice to "The long noncoding RNA CASC2 inhibits tumorigenesis through modulating the expression of PTEN by targeting miR-18a-5p in esophageal carcinoma" [Experimental Cell Research 361 (2017) 30-38].
Zhang W; He W; Gao J; Wang Y; Zang W; Dong Z; Zhao G
Exp Cell Res; 2018 Aug; 369(1):176. PubMed ID: 29880422
[No Abstract] [Full Text] [Related]
10. Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129].
Yao L; Zhou Y; Sui Z; Zhang Y; Liu Y; Xie H; Gao H; Fan H; Zhang Y; Liu M; Li S; Tang H
EBioMedicine; 2021 Oct; 72():103667. PubMed ID: 34717839
[No Abstract] [Full Text] [Related]
11. Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].
Hua X; Liu Z; Zhou M; Tian Y; Zhao PP; Pan WH; Li CX; Huang XX; Liao ZX; Xian Q; Chen B; Hu Y; Leng L; Fang XW; Yu LN
EBioMedicine; 2021 Oct; 72():103665. PubMed ID: 34717838
[No Abstract] [Full Text] [Related]
12. Retraction notice to 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells' [EBioMedicine 35 (2018) 204-221].
Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
EBioMedicine; 2021 Jan; 63():103168. PubMed ID: 33487222
[No Abstract] [Full Text] [Related]
13. Retraction notice to 'The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC' [EBioMedicine 37 (2018) 188-204].
Jin D; Guo J; Wang D; Wu Y; Wang X; Gao Y; Shao C; Xu X; Tan S
EBioMedicine; 2021 Jan; 63():103169. PubMed ID: 33487223
[No Abstract] [Full Text] [Related]
14. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Immunobiology; ; . PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
